INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 05, 2005 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 50,000 | -- | 50,000 |
| Dec 16, 2011 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 48,079 | -- | 48,079 |
| Dec 14, 2010 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 46,736 | -- | 46,736 |
| Dec 18, 2009 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 45,295 | -- | 45,295 |
| Jan 05, 2005 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 45,200 | -- | -- |
| Dec 17, 2008 |
SVP, Research & Devel Sciences
|
SVP, Research & Devel Sciences | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 44,048 | -- | 44,048 |
| Jul 24, 2009 |
SVP Res and Dev Sciences
|
SVP Res and Dev Sciences | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 42,154 | $20.14 | 47,659 |
| May 14, 2021 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | $179.13 | 64,280 |
| May 14, 2021 |
EVP Research and Development
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | -- | 72,500 |
| Feb 12, 2014 |
SVP Research and Development S
|
SVP Research and Development S | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | $21.25 | 64,391 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.